
In this article, the role of a triple-quadrupole mass spectrometer in performing in vitro studies of compound metabolic stability and identification of Phase I and II metabolites is demonstrated.
Ron A.H.J. Gilissen is with Johnson & Johnson Pharmaceutical Research & Development, 2340 Beerse, Belgium.

In this article, the role of a triple-quadrupole mass spectrometer in performing in vitro studies of compound metabolic stability and identification of Phase I and II metabolites is demonstrated.

Published: May 1st 2006 | Updated: